Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Arch Biopartners Inc (ARCH.VN)

Arch Biopartners Inc (ARCH.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Arch Biopartners Inc 545 King Street West Toronto ON M5V 1M1 CAN

https://www.archbiopartners.com P: 647-428-7031 F: 647-351-3565

Description:

Arch Biopartners Inc is a clinical stage company developing technologies with the potential to make medical or commercial impacts. The company is developing a drug platform Metablok to produce drug candidates to inhibit organ inflammation caused via the DPEP-1 pathway. It's under development portfolio is AB569, a potential new treatment for antibiotic resistant bacterial infections in the lungs or wounds; and, Borg peptide coatings that increase corrosion resistance and decrease bacterial biofilm on various medical grade metals and plastics.

Key Statistics

Overview:

Market Capitalization, $K 103,757
Shares Outstanding, K 63,851
Annual Sales, $ 0 K
Annual Net Income, $ -3,327 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -1,149 K
60-Month Beta 2.16
% of Institutional Shareholders 0.94%

Growth:

1-Year Return -21.87%
3-Year Return 20.37%
5-Year Return 40.09%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%

Per-Share Information:

Next Earnings Date N/A
Earnings Per Share ttm -0.03
EPS Growth vs. Prev Qtr -15.38%
EPS Growth vs. Prev Year -45.16%
Annual Dividend Rate, $ 0.00
Most Recent Dividend 0.200 on 09/13/00
Next Ex-Dividends Date 09/13/00
Dividend Payable Date 01/01/70
Dividend Payout Ratio 0.00%
Most Recent Split 1-3 on 11/25/03

ARCH.VN Ratios

Ratio
Price/Earnings ttm N/A
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % N/A
Return-on-Assets % -78.01%
Profit Margin % 0.00%
Debt/Equity N/A
Price/Sales N/A
Price/Book N/A
Book Value/Share -0.10
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar